Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about TAK

Recent news which mentions TAK

< Previous 1 2 3 4 5 6 7 8 9 Next >
Takeda-Protagonist Therapeutics Partnered Investigational Drug Hits Primary Goal In Late-Stage Study In Patients With Type Of Blood Cancer
Tickers NEWS PTGX TAK
Tags Stories That Matter PTGX TAK
From Benzinga
Earnings Scheduled For January 30, 2025
Tickers AAPL ABCB ABG AJG
Tags GEN PH CIVB
From Benzinga
Neurocrine Obtains Exclusive Rights For Depression Drug, Takeda Reacquires Japan Rights
Tickers NBIX NEWS TAK
Tags Contracts News Health Care
From Benzinga
FDA Bans Red Dye No. 3 Effective January 2027, Cites Cancer Risks: Food Stocks To Watch
Tickers ABT COST FOOD GIS
Tags Markets Market News TAK
From Benzinga
Takeda's HYQVIA Approved in Japan To Treat Immunodeficiency
Tickers ASIA NEWS TAK
Tags Movers General News
From Benzinga
Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
Tickers MRK NEWS RHHBY SNY
Tags Expert Ideas General RHHBY
From Benzinga
Keros Therapeutics' Licensing Deal With Takeda Aligns With Broader Opportunity For Elritercept: Analyst
Tickers KROS NEWS TAK
Tags KROS Analyst Ratings General
From Benzinga
AC Immune's Active Immunotherapy Shows Antibody Responses In Early Parkinson's Patients
Tickers ACIU NEWS TAK
Tags Benzinga Health Care ACIU
From Benzinga
Urgency, Debate Mark COP29 As Leaders Push For Carbon Market Rules, Worry About Trump
Tickers F FAN ICLN NEWS
Tags energy Global News
From Benzinga
Preview: Takeda Pharmaceutical's Earnings
Tickers TAK
Tags Market News TAK Benzinga
From Benzinga
Alumis' Investigational Lead Candidate Supports Superior Profile Than Bristol Myers' Commercialized Drug, Analyst Sees 170% Stock Upside
Tickers ALMS BMY NEWS TAK
Tags Expert Ideas General Analyst Ratings
From Benzinga
Johnson & Johnson Ends Phase 2 Study For Dengue Antiviral Amid R&D Reprioritization
Tickers JNJ NEWS TAK
Tags Stories That Matter TAK Market News
From Benzinga
Protagonist Therapeutics' Two Investigational Candidates Target Over $10B Market, Bullish Analyst Opines
Tickers JNJ NEWS PTGX TAK
Tags Analyst Ratings Expert Ideas JNJ
From Benzinga
Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
Tickers AZN BMY ELVN NEWS
Tags ELVN Movers AZN
From Benzinga
Shortage Relief: More Takeda's Vyvanse For ADHD On the Way As US Ramps Up Production
Tickers HKMPF HKMPY MCKPF MNKTQ
Tags General VTRS Large Cap
From Benzinga
Ascendis' Hypoparathyroidism Drug Scores FDA Approval As First and Only Treatment, Replacing Takeda's Drug Discontinued Due To Supply Issues
Tickers ASND NEWS TAK
Tags ASND Equities Stories That Matter
From Benzinga
Why Is Japanese Drugmaker Takeda Pharmaceutical Stock Trading Higher On Wednesday?
Tickers NEWS TAK
Tags Briefs Biotech Top Stories
From Benzinga
TAK Stock Earnings: Takeda Pharmaceutical Reported Results for Q1 2024
Tickers TAK
Tags Earnings Reports Market News NYSE:TAK
From InvestorPlace
3 Biotech Stocks to Buy on the Dip: July 2024
Tickers JAZZ PCRX TAK
Tags NASDAQ:JAZZ,NYSE:TAK,NASDAQ:PCRX TAK Market News
From InvestorPlace
Newly-Listed Psoriasis-Focused Alumis Attracts Analysts' Attention With Promising Lead Program And Modest Valuation
Tickers ALMS BMY JNJ NEWS
Tags Analyst Color Equities Stories That Matter
From Benzinga
Eli Lilly's $3.2B Morphic Deal Is 'Crucial,' Has 'Strategic Merit' Despite Investor Attention On Obesity: Analyst
Tickers LLY MORF NEWS TAK
Tags General Expert Ideas Large Cap
From Benzinga
Blackstone Nears $2.2B Deal For Sale Of Japanese Supplement Maker Alinamin: Report
Tickers BX LBO NEWS PSP
Tags Asset Sales LBO BX
From Benzinga
NextEra Energy, Lennar And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Tickers BTDR LEN NEE NEWS
Tags Markets NEE Trading Ideas
From Benzinga
Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Tickers AAN AGRI ALLG AMCX
Tags EVO VERO Movers
From Benzinga
What's Going On With Ovid Therapeutics After Takeda's Two Phase 3 Epilepsy Studies Fail?
Tickers NEWS OVID TAK
Tags Trading Ideas TAK Market News
From Benzinga
Japan Pharma Giant Takeda's Anti-Seizure Treatment Flunks In Two Late-Stage Studies
Tickers NEWS TAK
Tags Briefs Biotech Market News
From Benzinga
7 F-Rated Stocks to Avoid at All Costs in June
Tickers AKTS BSFC HLTH LCID
Tags Market News HLTH TAK
From InvestorPlace
Blackstone Weighs Sale Of Japanese Pharma Firm Alinamin: Report
Tickers BX EQBBF NEWS TAK
Tags News Stories That Matter Equities
From Benzinga
Google DeepMind CEO: ‘This Is the Next $100 Billion AI Business’
Tickers AZN CRBP JANX MSFT
Tags TAK NVDA Market News
From InvestorPlace
Takeda's Dengue Vaccine Gets WHO Approval, Eligible for UN Procurement
Tickers NEWS SNY TAK
Tags Large Cap General News
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.